Use a textile method, but specify the exact ISO 20743 option
A typical rail blanket brief sounds simple: 130 x 170cm finished size, 230gsm polyester microfleece, dark navy, overlocked edges, belly-band packed, reusable, antibacterial treated. The weak version is one line such as "blanket must be antibacterial and retain performance after washing". That leaves core gaps: no named test standard, no method option, no named strains, no wash protocol, no sample basis, no lot definition, and no release gate tied to shipped goods.
For a pile textile such as polyester microfleece, ISO 20743 is commonly used as the textile antibacterial test framework because it is written for textile products. That does not mean every lab will run it the same way. ISO 20743 contains multiple method options and calculation routes, and comparability can shift with method option, specimen preparation, inoculum handling, incubation conditions and the way the result is calculated. The buyer should require the lab to state the exact ISO 20743 option in the quotation, approval reports and shipment-release report, and the same option should be kept through all stages of the programme.
Do not assume that one method option is inherently correct for hydrophobic microfleece. Pile polyester can behave differently from absorbent fabrics, and suitability depends on product construction and the lab's validated capability. The buyer should require the testing lab to justify the chosen ISO 20743 method for 230gsm pile polyester and confirm that the same method option will be used for development, pre-production and release testing. If the development report uses one option and the shipment report uses another, the values should not be treated as directly comparable.
ISO 22196 is not the routine release method for fleece blankets. It is intended for measuring antibacterial activity on non-porous surfaces and materials, so it is generally not appropriate as a shipment-release standard for textile blankets. Legacy chemistry data to ISO 22196 can still be useful as background evidence from the finish supplier, but it should not replace a textile-based release requirement on a porous pile article. Buyers comparing adjacent microfleece programmes can also review 240gsm RPET microfleece blankets with antibacterial finish tested to ISO 20743 and how to specify 200gsm recycled fleece blankets for airline amenity programmes.
Name strains, reporting basis and wash variables in the tender
Do not write "tested against bacteria" in the tender. Name the organisms with strain identifiers, for example Staphylococcus aureus ATCC 6538 and Klebsiella pneumoniae ATCC 4352, if that pair is available under the chosen ISO 20743 method at the selected laboratory. Some laboratories routinely offer other strain sets such as Escherichia coli ATCC 8739 in place of K. pneumoniae. Either may be acceptable, but the pair is only an example and must be confirmed against the lab's accredited or routine offering before the PO is issued. Otherwise, two suppliers can each submit compliant-looking reports that are not comparable.
The reporting metric also needs tight wording. Under ISO 20743, the primary result is typically reported as an antibacterial activity value under the defined calculation route. Buyers sometimes ask for "log reduction" because it is commercially familiar, but that should not be treated as an interchangeable market number unless the conversion basis, control counts and method route are clearly stated. The cleaner requirement is for the laboratory to report: standard, method option, named strains with identifiers, inoculation approach, incubation conditions, untreated control result, treated result, and the final antibacterial activity value exactly as calculated under the selected ISO 20743 route.
Wash durability must be locked down with the full ISO 6330 laundering variables, not just a cycle count. For comparability, specify the machine type or reference washer, programme, wash temperature, reference detergent or detergent type, load mass, drying method, and whether the cycles are consecutive on the same specimens. If the buyer wants 5-cycle and 10-cycle checkpoints, say so explicitly. Without these variables, two reports both labelled "after 10 washes" can differ materially.
For reusable rail blankets, a workable approval structure is often initial activity on unwashed specimens plus retained activity after 5 or 10 ISO 6330 cycles. That is not a universal rule; feasibility depends on the finish chemistry, shade, softener package, cure conditions and the selected ISO 20743 option. Unsupported numeric pass thresholds should not be copied from another tender as if they were standard requirements. If a buyer wants a commercial benchmark, it should be stated as an internal programme target and validated during development rather than treated as an implied industry norm. For laundering alignment, see ISO 6330 home laundering protocols for polyester flannel throws.
Separate tender spec, PO, development protocol and shipment release
Many antibacterial blanket programmes get muddled because the tender, purchase order, development protocol and shipment release package all ask for different things. Keep them separate. The tender spec should define the commercial requirement: 230gsm polyester microfleece rail blanket, target size, colour, antibacterial test framework, named strains, wash checkpoint, workmanship plan and claim boundary. The PO should lock the exact standard references, tolerances, approved lab, sample basis and release documents. The development protocol should define who submits samples, how many specimens are needed, which shade and finish route are being trialled, and what counts as approval before bulk. The shipment release package should state what documents must accompany the shipped lot.
For laboratory competence, require the test lab to be ISO/IEC 17025 accredited for the relevant method, or to disclose clearly if the requested test is outside accredited scope. That point belongs in the tender and PO, not only in internal notes. If the selected lab can run ISO 20743 only as a routine but non-accredited method, the buyer should know that before booking bulk production.
A sourcing manager can paste this short model clause into the tender: "Antibacterial performance to be evaluated on textile blanket material under ISO 20743 using one agreed method option only, applied consistently through development, pre-production and shipment release. Laboratory shall state method option, strain identifiers, calculation route, and whether testing is within ISO/IEC 17025 accredited scope. ISO 22196 data may be submitted as supplementary chemistry information only and shall not replace textile release testing."
For product construction and baseline specs, related fleece programmes include 280gsm polyester fleece rail travel blankets with elastic luggage strap and travel and airline blanket weight and packing guidance.
Define sample basis, lot control and AQL interaction properly
The sample basis determines whether the test result represents the goods being shipped. For a finished blanket buyer, bulk treated fabric can be acceptable for development approval and for confirming whether the finish route is working on the intended shade and construction. It is less complete as a shipment-release basis if the final order includes multiple finishing lots, mixed dye lots, or subcontracted sewing and packing across different days. Finished-goods testing becomes more relevant when cutting, sewing, packing, lot mixing or accessory contact could affect shipment identity and traceability.
A practical structure is: development approval on pilot or trial-finished fabric; pre-production approval on bulk fabric from the actual finishing route, shade and chemistry recipe; and shipment release on specimens randomly drawn from packed finished goods, with the sampled blankets traceable back to the bulk finishing lot. If the shipment is a single homogeneous lot from one finishing batch, bulk-fabric release testing may be commercially acceptable if agreed in writing. If the shipment is mixed across lots or pack dates, finished-goods sampling is the safer basis.
State the sample quantity and custody rules. For example: at least 3 finished blankets per shipment lot for retained reference, with laboratory specimens cut from randomly selected packed goods by buyer representative, third-party inspector, or jointly witnessed factory QC; sample bags sealed and labelled with PO, style, colour, lot code, carton number and date; one retained by the lab, one by the supplier, one by the buyer or inspection agent where practical. If bulk-fabric specimens are used, the PO should state how many rolls are sampled, whether roll ends or mid-roll sections are taken, and how roll IDs are linked to blanket lots.
AQL language also needs precision. Specify whether AQL 2.5, General Inspection Level II applies to finished packed blankets, retail packs, outer cartons, or all three. Antibacterial release and AQL are not fully separate if they share the same lot definition and sampling event. A common structure is visual and measurement inspection on finished packed blankets and packaging under AQL, with antibacterial specimens drawn from the same defined shipment lot but tested under a separate laboratory protocol. For inspection discipline, see AQL 2.5 inspection checklist for fleece blankets and blanket quality control inspection.
Alongside the antibacterial gate, the buyer should still write normal blanket tolerances. A commercially usable baseline for 230gsm microfleece is often GSM tolerance ±5% on greige-to-finished agreed basis, finished size tolerance ±2cm on a 130 x 170cm blanket, overlock seam integrity with no skipped stitches longer than about 25mm in visible areas, shade approval to signed standard under D65 or equivalent light source, and workmanship inspection to the agreed AQL plan. Exact tolerances remain supplier- and construction-dependent and should be confirmed during sampling.
Finish chemistry, durability risk and compliance boundaries
Most 230gsm polyester microfleece antibacterial programmes use a topical post-finish after dyeing, followed by drying and cure. That route fits normal fleece production, but it is also where wash durability, handfeel shift and shade drift need control. Intrinsic antibacterial fibre routes exist, but they are less common on this category and can raise MOQ materially because yarn sourcing and colour flexibility narrow.
Buyers should request chemistry disclosure at the level needed for compliance without demanding a full proprietary formula. A practical request is: active technology class or functional chemistry type, declaration of intended textile-use suitability, restricted-substance compliance statement for the destination market, and confirmation that the claimed care label is compatible with the finish durability claim. That gives the buyer enough compliance control without forcing the supplier to disclose protected formulation details.
Failure modes on dark navy microfleece are usually more commercial than dramatic. Common issues include harsher hand after cure, slight loss of shade depth, patchy performance if wet pick-up or curing dwell drifts, face-versus-reverse pile variation, and weaker durability after repeated laundering than the pre-wash data suggested. Those risks should be surfaced during development, not discovered after carton packing.
MOQ, lead time and cost are supplier-dependent and construction-dependent. In practice, an antibacterial-finished navy microfleece programme may require a fuller finishing run than a standard untreated order, and third-party testing can add around 1 to 3 weeks depending on lab queue, resubmission risk and whether wash durability cycles are run in sequence. The direct chemical upcharge per piece is often less significant than the cost of failed approvals, repeat finishing or delayed dispatch. Buyers balancing recycled content or shade continuity can cross-check RPET polar fleece blankets with GRS documentation and solution-dyed 220gsm polyester fleece blankets: MOQ, shade continuity and trade-offs.
Claims, labeling and rail-market compliance checks
A rail buyer should keep the claim language inside the evidence boundary. Safer wording is "antibacterial treated textile" or "treated with an antibacterial finish; performance verified by agreed textile test method". Avoid medical, antiviral, infection-prevention, self-disinfecting, permanent-protection or public-health language unless the target market review supports it. Blanket packaging, belly bands, carton marks, care labels and tender documents should all use the same claim boundary.
Destination-market rules also matter. Depending on where the blankets will be sold or distributed, antibacterial treated-article wording can trigger biocide disclosure, treated-article labeling, customer communication controls or restrictions on how performance claims are presented. A rail operator buying for the UK or EU market should ask its compliance team or importer of record to review treated-article obligations before approving packaging copy. That review sits alongside REACH, care labeling and any customer-facing claim approval; it is not replaced by a laboratory pass report.
A practical PO line is: "No antiviral, antifungal, medical-device, therapeutic, infection-prevention, self-cleaning, sterilising or permanent-performance claims permitted on product, packaging, tenders or sales literature unless separately approved in writing by buyer following destination-market compliance review." For general compliance framing, buyers may also refer to textile certifications explained for buyers.
PO-ready release table and tender checklist
Use a staged release table rather than one blanket sentence. Development approval: pilot or trial-finished navy 230gsm microfleece, tested to one agreed ISO 20743 method option, named strains with identifiers, and initial plus post-laundering results reported under one fixed calculation route. Pre-production approval: actual bulk finishing route, actual shade, actual softener package, same laboratory method option, same strains, same wash variables. Shipment release: shipment lot defined by PO and packing list, samples randomly drawn from packed finished goods or another agreed representative basis, AQL inspection report, GSM and size records, shade approval, and antibacterial report linked to lot codes.
A concise tender checklist buyers can paste into sourcing documents is: product: 230gsm polyester microfleece rail blanket, 130 x 170cm, navy, overlocked edges, belly-band packed. antibacterial test: ISO 20743, exact method option to be named by lab and fixed across all approvals. organisms: full strain identifiers to be listed in PO. wash durability: ISO 6330 with machine/reference washer, programme, temperature, detergent, load, drying method and cycle sequence defined. lab status: ISO/IEC 17025 accredited for relevant method or outside-scope status declared. sample basis: quantity, lot definition, sampler, sealing and retention rules stated. shipment docs: test report, lot traceability, AQL report, measurement summary, packing list and carton marks. claims: no medical or public-health wording without destination-market approval.
That checklist gives the buyer something enforceable at tender stage and saves time later in PO negotiation, lab booking and final release. If the supplier cannot quote against that level of definition, the buyer is not comparing like with like.
Frequently asked
Should a rail blanket buyer use ISO 20743 or ISO 22196? For 230gsm polyester microfleece blankets, ISO 20743 is the textile-specific framework commonly used for antibacterial evaluation. ISO 22196 is for non-porous materials and is generally not suitable as the shipment-release method for fleece blankets. A chemistry supplier may provide ISO 22196 data as supplementary evidence, but it should not replace textile release testing on the blanket programme.
Which ISO 20743 method option should be used for microfleece? Do not assume one option is automatically correct for hydrophobic pile polyester. The lab should justify the selected ISO 20743 method option for the specific 230gsm microfleece construction and then keep that same option through development, pre-production and shipment release. Changing method option mid-programme undermines comparability.
How should the antibacterial result be written in the PO? Require the laboratory to report the exact ISO 20743 method option, named strains with identifiers, inoculation and incubation conditions, untreated control result, treated result, and the final antibacterial activity value under the calculation route used by the standard. If your sourcing team also wants a commercial log-reduction comparison, state the conversion basis separately and do not treat it as universally interchangeable across methods.
What wash details must be fixed for ISO 6330 durability comparisons? Specify machine type or reference washer, programme, wash temperature, detergent or reference detergent, load mass, drying method, and whether all cycles are consecutive on the same specimens. A statement such as "after 10 washes" is too loose for supplier comparison if those variables are missing.
Should release testing be done on bulk fabric or on finished blankets? For development and pre-production, bulk fabric can be acceptable because it isolates the finishing lot and gives cleaner traceability to the chemistry run. For shipment release, finished-goods sampling is often stronger if the order includes mixed finishing lots, mixed dye lots, or multiple sewing and packing batches. If bulk fabric is used for release, the PO should state exactly why it is representative of the shipment lot.
How does AQL interact with antibacterial testing? AQL and antibacterial testing are different controls, but they should use a consistent shipment-lot definition. AQL may apply to finished packed blankets, retail packs, outer cartons, or all of them depending on the PO. Antibacterial specimens can be drawn from the same defined lot while being tested under a separate lab protocol.
What should the buyer request about the finish chemistry without asking for a full formula? Ask for the active technology class or chemistry type, a restricted-substance compliance declaration for the destination market, and confirmation that the care-label instructions are compatible with the claimed durability. That usually gives enough sourcing control without requiring full proprietary formulation disclosure.
Do antibacterial claims create extra compliance work for rail buyers? They can. In some destination markets, treated-article or biocide rules affect labeling, disclosure and customer-facing claim wording. A lab pass report does not by itself clear those obligations, so the buyer or importer of record should review treated-article requirements before approving packaging or sales copy.
Have a project in mind? Send us your spec — we'll reply within one business day with indicative pricing and a sample plan.